Clinical trial
Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host…
NCT00201786 · Ohio State University Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00201786 |
|---|---|
| Title | Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease |
| Official title | Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease |
| Lead sponsor | Ohio State University Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft-Versus-Host Disease |
| Intervention type | Drug |
| Interventions | Pentostatin |
| Enrollment | 8 |
| Start date | Jul 1, 2003 |
| Primary completion | Oct 1, 2007 |
| Completion | Jul 1, 2013 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 27, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: